This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Monica Morrow, MD; Robert Schmidt, MD; Betsy Cregger; Cathy Hassett, RN; Susan Cox, RN

Arch Surg. 1994;129(10):1091-1096.

Abstract
Objective
To prospectively evaluate a program of additional mammographic views, interval follow-up, and stereotactic biopsy in the management of abnormalities detected on mammograms.

Methods
From June 1988 to September 1991, 267 consecutive women who were referred for surgical consultation because of an abnormal mammographic finding were evaluated. Mammographic abnormalities were assessed as benign or as requiring interval follow-up, stereotactic biopsy, open surgical biopsy, or additional views. Women having additional mammographic views were reassigned to the preceding groups. The mean follow-up for women who did not have a biopsy was 37 months.

Results
Only 129 (48%) of the women who were sent for surgical consultation underwent open biopsy, and 46 (36%) of the biopsy specimens revealed carcinoma. Forty-one (89%) of the cancers were ductal carcinoma in situ or stage I lesions. Of the 117 women who were assigned to follow-up, six (5%) subsequently required biopsy and two cancers were identified.

Conclusion
Rigorous mammographic evaluation and the use of stereotactic biopsy for selected lesions can prevent breast biopsy for low-suspicion mammographic abnormalities while still allowing the detection of early-stage breast cancer.

(Arch Surg. 1994;129:1091-1096)

Author Affiliations
From the Departments of Surgery (Dr Morrow and Mss Cregger and Hassett) and Radiology (Dr Schmidt and Ms Cox), University of Chicago (Ill). Dr Morrow is now with the Department of Surgery, Northwestern University, Chicago.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Management of Patients with Ductal Carcinoma-in-Situ
Chabner et al.
The Oncologist 1997;2:76-82.
ABSTRACT | FULL TEXT  

A 47-Year-Old Woman With Ductal Carcinoma In Situ of the Breast
Kaufman
JAMA 1996;275:1477-1477.
ABSTRACT  

A 47-Year-Old Woman With Ductal Carcinoma In Situ
Morrow
JAMA 1996;275:61-66.
ABSTRACT